US Earnings Financial Results SEC Filings — May 19, 2026

19-05-2026

Driven Brands Holdings Inc. reported total net revenue of $1.86B for fiscal year 2025, up 6.3% from $1.75B in 2024, driven by strong growth in Take 5 and Auto Glass Now segments. However, total consolidated same-store sales growth slowed to 1.0% in 2025 from 1.5% in 2024, with Franchise Brands posting a same-store sales decline of 1.1%. Adjusted EBITDA increased modestly by 1.3% to $449.1M, while net income surged to $132.1M from $0.5M in 2024, reflecting improved profitability.

• · Company-operated store sales grew 9.9% to $1.29B in 2025, representing 69.5% of total net revenue, up from 67.3% in 2024.
• · Franchise royalties and fees were essentially flat at $190.1M in 2025 vs $188.6M in 2024, but declined as a percentage of revenue from 10.8% to 10.2%.
• · Supply and other revenue decreased 4.7% to $268.9M in 2025 from $282.0M in 2024.
• · Selling, general, and administrative expenses increased 6.7% to $496.3M in 2025, representing 26.6% of revenue (vs 26.5% in 2024).
• · Asset impairment charges and lease terminations improved significantly, declining 50.3% to $28.1M in 2025 from $56.5M in 2024.
• · Interest expense, net decreased 22.8% to $121.2M in 2025 from $157.0M in 2024, reflecting lower debt levels or better rates.
• · Foreign currency transaction gain of $14.7M in 2025 compared to a loss of $17.5M in 2024.
• · Income tax benefit of $12.8M in 2025 vs expense of $24.5M in 2024, driven by a $37.8M valuation allowance reversal on deferred tax assets.
• · Adjusted net income from continuing operations increased 14.0% to $199.2M in 2025 from $174.8M in 2024.
• · Franchise Brands segment Adjusted EBITDA declined 6.3% to $178.8M in 2025 from $190.8M in 2024, and its margin contracted from 64.6% to 62.7%.
• · Take 5 segment Adjusted EBITDA grew 10.1% to $418.7M in 2025, but its margin slipped from 35.5% to 34.4%.
• · Auto Glass Now segment Adjusted EBITDA more than doubled to $25.9M in 2025 from $12.6M in 2024, with margin expanding from 5.3% to 10.0%.
• · Total store count increased by 175 stores (4.3%) to 4,252, driven by Take 5 adding 161 stores (13.6% growth).
• · Auto Glass Now store count declined by 6 stores (2.8%) to 211.
• · Franchise Brands store count grew by only 20 stores (0.7%) to 2,699.

19-05-2026

Oramed Pharmaceuticals reported a net income of $38.3M for Q1 2026, a significant turnaround from a net loss of $7.6M in Q1 2025, driven by $44.8M in financial income and $8.3M in other income. However, the company had zero revenue in Q1 2026 compared to $2.0M in Q1 2025, and operating loss improved only modestly to $3.7M from $4.5M. Cash and cash equivalents dropped sharply to $13.2M from $45.9M at year-end 2025, largely due to $11.9M in Lifeward transactions and $10.4M in dividend payments.

• · The company held $102.3M in investment in associate at fair value as of March 31, 2026, up from $71.6M at year-end 2025.
• · Deferred tax liabilities increased to $17.7M from $7.9M at December 31, 2025.
• · Basic earnings per share were $0.94 in Q1 2026 versus a loss of $0.19 in Q1 2025.
• · Weighted average diluted shares outstanding were 41,970,186 in Q1 2026, up from 41,228,782 in Q1 2025.
• · The company recognized a $5.8M gain on sale of IP in Q1 2026.
• · Net cash used in operating activities was $2.9M in Q1 2026, compared to $3.5M in Q1 2025.
• · The company invested $11.9M in Lifeward transactions, acquiring 1,250,363 ordinary shares (45.0% stake) and 1,006,113 pre-funded warrants.
• · Dividends paid totaled $10.4M in Q1 2026.
• · Stock-based compensation was $1.7M in Q1 2026, down from $2.2M in Q1 2025.

19-05-2026

Educational Development Corp (EDUC) reported a net profit of $2.3M for FY2026, a significant turnaround from a net loss of $5.3M in FY2025. Net revenues declined 33% to $22.9M, driven by a 35% drop in its PaperPie direct sales division, where active Brand Partners fell 53% to 5,800. However, profitability improved due to a large $12.2M gain on asset sales, lower operating expenses, and reduced interest costs.

• · EPS: Basic and diluted earnings per share were $0.27 in FY2026, compared to a loss of ($0.63) in FY2025.
• · Weighted average basic shares outstanding: 8,563,491 in FY2026 vs. 8,348,971 in FY2025.
• · Gross margin decreased 35.3% to $13.6M, but gross margin percentage improved slightly to 59.4% from 61.5%.
• · Interest expense decreased 32.4% to $1.5M from $2.2M.
• · Operating cash flow not provided, but cash and cash equivalents increased to $1.1M from $0.4M.
• · Line of credit was fully paid down to $0 from $4.2M; current maturities of long-term debt reduced to $0 from $26.7M.
• · Assets held for sale dropped to $0.6M from $19.3M, indicating a significant asset disposal/sale during the year.
• · Deferred income tax asset went to $0 from $2.5M.
• · Operating lease right-of-use assets increased to $6.7M from $1.1M, while operating lease liabilities (current + noncurrent) increased to $6.7M from $1.1M.
• · Inventory (net) total (current + noncurrent) decreased to $37.7M from $44.7M.
• · Retained earnings increased to $39.6M from $37.3M due to FY2026 profit.
• · No dividends were paid in either period.

19-05-2026

Natural Alternatives International Inc (NAII) reported a net loss of $4.3M for Q3 FY2026, widening from a $2.2M loss in the prior year quarter, as gross profit plummeted 79% to $0.4M due to cost of goods sold nearly matching net sales. For the nine months, net loss increased to $7.2M from $6.4M, while net sales grew 23% to $35.5M in Q3 and 13% to $108.0M year-to-date. However, operating loss deepened to $4.0M in Q3 from $2.1M, and cash flow from operations turned negative at -$7.9M for the nine months versus positive $2.6M a year ago.

• · Cost of goods sold for Q3 FY2026 was $35.1M, nearly equal to net sales of $35.5M, resulting in a gross margin of only 1.1%.
• · Selling, general and administrative expenses increased 12% to $4.4M in Q3 FY2026 from $3.9M in Q3 FY2025.
• · Interest expense rose to $0.27M in Q3 FY2026 from $0.25M in the prior year quarter.
• · Foreign exchange gain of $0.05M in Q3 FY2026 versus a loss of $0.34M in Q3 FY2025.
• · Net cash used in operating activities for nine months was $7.9M, compared to $2.6M provided in the prior year period.
• · Borrowings on line of credit increased by $8.1M during the nine months, compared to a net repayment of $1.4M in the prior year period.
• · Total assets increased to $154.9M at March 31, 2026 from $151.9M at June 30, 2025.
• · Total liabilities increased to $91.8M from $83.5M, primarily due to higher line of credit balance.
• · Stockholders' equity decreased to $63.1M from $68.4M, driven by net losses and share repurchases.
• · The company repurchased 29,884 shares for $0.082M during Q3 FY2026.

19-05-2026

AlphaVest Acquisition Corp. reported a net income of $145,601 for Q1 2026, reversing a net loss of $77,177 in Q1 2025. However, total revenues declined 33.9% to $1,184,616 from $1,792,525, driven by a sharp drop in product revenue. Cash and cash equivalents decreased to $6,632,619 from $7,004,601 at year-end 2025.

• · Gross profit improved to $1,020,656 from $488,330, a 109% increase.
• · Operating income was $128,539 compared to an operating loss of $747,753.
• · Total operating expenses decreased 27.8% to $892,117 from $1,236,083.
• · Cash used in operating activities was $391,580 vs. cash provided of $203,985 in prior year.
• · Accounts receivable - related party increased to $3,114,877 from $2,065,890.
• · Inventories decreased to $914,678 from $1,069,465.
• · Accumulated deficit improved to $27,192,508 from $27,338,109.

19-05-2026

Energy Vault Holdings, Inc. reported Q1 2026 revenue of $21.9M, up 156% YoY from $8.5M, driven by a surge in energy storage product sales ($19.7M vs $4.9M). However, the company's net loss widened to $32.5M from $21.1M, and operating expenses rose 12.5% to $29.0M, primarily due to higher G&A costs. Cash used in operations increased sharply to $53.8M from $2.7M, while total stockholders' equity fell 55% to $30.5M from $67.5M at year-end 2025.

• · Revenue from sale of energy storage products surged to $19.7M in Q1 2026 from $4.9M in Q1 2025.
• · IP licensing revenue dropped sharply from $3.3M to $15K YoY.
• · General and administrative expenses rose 21.3% to $21.2M from $17.5M.
• · Cash used in operating activities was $53.8M in Q1 2026 vs $2.7M in Q1 2025.
• · The company issued $150M in debt and repaid $56.5M during Q1 2026.
• · Total restricted cash increased to $61.9M from $45.2M at year-end 2025.
• · Contract liabilities grew to $15.4M from $6.6M at December 31, 2025.
• · Net loss per share was $(0.20) in Q1 2026 vs $(0.14) in Q1 2025.

19-05-2026

IRIDEX CORP reported net loss of $524K for Q1 FY26 (three months ended April 4, 2026), a significant improvement from a $1,686K net loss in the same prior-year period, driven by a sharp reduction in other expenses ($142K vs. $1,469K). However, total revenues declined slightly by 0.8% to $11,799K from $11,896K year-over-year, with gross profit also falling from $5,055K to $4,741K as cost of revenues increased, and cash used in operations deepened to $1,335K from $1,149K, reflecting a weak operating cash flow trend.

• · Gross margin contracted to 40.2% in Q1 FY26 from 42.5% in the prior-year period, reflecting higher costs.
• · Operating expenses decreased 3.7% YoY, driven by a 16% reduction in G&A ($1,623K vs. $1,931K), while R&D and sales & marketing increased modestly.
• · Cash used in operating activities deepened to $1,335K in Q1 FY26 from $1,149K in Q1 FY25, primarily due to inventory build of $1,448K.
• · Total deferred revenue at the end of Q1 FY26 was $8,462K, down from $10,058K at the end of the prior-year period, indicating a declining backlog.
• · Working capital decreased to $11,756K (current assets of $24,584K minus current liabilities of $12,828K) from $12,044K at the start of the fiscal year.
• · Stockholders' equity declined to $4,732K from $4,922K at January 3, 2026.
• · No new debt or equity was raised in Q1 FY26, compared to $4,000K from a convertible note and $6,000K from Series B preferred in the prior-year period.

19-05-2026

Sono Group N.V. reported a net loss of $2.0M for Q1 2026, swinging from a $7.8M net income in Q1 2025, driven by a $1.0M loss from continuing operations and a $1.0M loss from discontinued operations. The company raised $6.4M in financing (convertible debentures and pre-funded warrants) and invested $5.0M in a Bitcoin treasury, which now stands at $4.7M. However, total liabilities exceeded total assets, resulting in negative shareholders' equity of ($0.5M) as of March 31, 2026, compared to ($0.1M) at year-end 2025.

• · General and administrative expenses increased 14.6% YoY to $1.2M in Q1 2026 from $1.0M in Q1 2025.
• · Digital asset treasury loss, net was $313K in Q1 2026 (no comparable in Q1 2025).
• · Derivative liabilities from embedded conversion features totaled $3.7M as of March 31, 2026.
• · Convertible notes payable, net of discount, stood at $699K as of March 31, 2026.
• · Accumulated deficit widened to ($335.4M) as of March 31, 2026 from ($333.4M) at December 31, 2025.
• · Net cash used in operating activities improved to ($1.4M) in Q1 2026 from ($2.6M) in Q1 2025.
• · Assets of discontinued operations classified as held for sale were $1.0M as of March 31, 2026.
• · Liabilities of discontinued operations classified as held for sale were $1.0M as of March 31, 2026.

19-05-2026

Cisco reported strong Q3 FY2026 results with total revenue of $15,841M, up 12.0% YoY from $14,149M, driven by product revenue growth of 16.8% to $12,117M. Net income rose 35.4% to $3,373M ($0.85 per diluted share) from $2,491M ($0.62 per diluted share). However, services revenue declined 1.4% YoY to $3,724M, and operating cash flow decreased 11.7% to $8,791M for the nine-month period, reflecting higher inventory and lower deferred revenue.

• · Gross margin for Q3 FY2026 was $10,080M, up from $9,278M in Q3 FY2025.
• · Total operating expenses for Q3 FY2026 were $6,120M, relatively flat compared to $6,076M in Q3 FY2025.
• · Restructuring and other charges were a credit of $1M in Q3 FY2026 versus a charge of $34M in Q3 FY2025.
• · Interest and other income (loss), net was $79M in Q3 FY2026, compared to a loss of $255M in Q3 FY2025.
• · Provision for income taxes increased to $666M in Q3 FY2026 from $456M in Q3 FY2025.
• · Cash dividends declared were $0.42 per common share in Q3 FY2026, up from $0.41 in Q3 FY2025.
• · Share repurchases totaled $1,252M in Q3 FY2026, compared to $1,504M in Q3 FY2025.
• · Inventories increased to $4,708M at April 25, 2026 from $3,164M at July 26, 2025.
• · Short-term debt rose to $11,932M from $5,232M at July 26, 2025.
• · Long-term debt decreased to $19,371M from $22,861M at July 26, 2025.

19-05-2026

Red Robin Gourmet Burgers Inc. reported total revenues of $378.3M for the 16 weeks ended April 19, 2026, down 3.6% from $392.4M in the prior-year period, driven by a 3.8% decline in restaurant revenue. The company swung to a net loss of $2.2M (or -$0.12 per diluted share) from net income of $1.2M ($0.07 per diluted share) a year ago, as operating income fell 39.4% to $5.5M. However, cash and cash equivalents increased to $24.3M from $19.9M at year-end 2025, and operating cash flow remained positive at $7.0M, though down sharply from $19.6M in the prior period.

• · Cost of sales decreased 1.6% YoY to $86.6M, while labor costs fell 7.5% to $132.4M.
• · General and administrative expenses declined 14.4% to $23.1M, partly due to lower stock-based compensation ($1.7M vs $2.6M).
• · Selling expenses increased 41.3% to $13.2M from $9.4M.
• · Other charges, net rose to $4.8M from $0.7M, including $0.5M in asset impairment.
• · Interest expense decreased 3.6% to $7.8M.
• · Net cash used in investing activities was $6.7M, down from $6.4M, with capital expenditures of $6.7M.
• · Financing activities provided $4.1M, primarily from $5.5M in net borrowings on the revolving credit facility.
• · Unearned revenue fell 38.3% to $16.8M from $27.3M at year-end 2025, driven by a decline in unearned gift card revenue.
• · Total assets decreased 3.5% to $543.8M from $563.5M at year-end 2025.
• · Stockholders' deficit widened slightly to $106.7M from $106.3M.

19-05-2026

James Hardie Industries reported a mixed FY26 annual result. While consolidated net sales grew 25% YoY to $4,835.8M, driven by the AZEK acquisition, GAAP net income plummeted 75% to $104.0M and operating income fell 32% to $447.6M. The sharp profit decline was primarily due to $206.9M in acquisition-related expenses, $178.7M in amortization of intangible assets from the AZEK acquisition, and significantly higher SG&A expenses (+59% to $946.4M). On an adjusted EBITDA basis, which excludes these items, performance was stronger with adjusted EBITDA up 17% to $1,265.8M, though adjusted EBITDA margin contracted 1.6 pts to 26.2%.

• · North America Fiber Cement segment (Table 2): net sales $2,963.1M (+3%), gross margin declined 2.2 pts to 37.7%, SG&A +28%, R&D +280%, operating income -21% to $661.9M.
• · AZEK segment (Table 3): FY26 net sales $795.2M, gross margin 27.1%, operating loss of $17.7M with SGA expense of $222.3M.
• · Europe Building Products segment (Table 4): net sales essentially flat at $520.6M, operating income +39% to $153.9M driven by restructuring expense decline from $50.3M to $1.4M.
• · Asia Pacific segment (Table 5): net sales +13% to $556.9M, operating income +37% to $52.2M.
• · Debt and cash: cash provided by financing activities surged to $3,350.9M from ($165.9M) due to debt financing for the AZEK acquisition; investing cash outflows were $4,208.5M vs $446.7M in FY25.
• · Adjusted net income reconciliation (Table 8): key addbacks in FY26 include amortization of intangible assets from AZEK acquisition $178.7M, acquisition related expenses $206.9M, and inventory fair value adjustment $47.9M.
• · GAAP net income margin collapsed to 2.2% from 10.9% in FY25 and 13.0% in FY24; adjusted EBITDA margin also declined from 27.8% to 26.2%.

19-05-2026

Mangoceuticals, Inc. reported a net loss of $3.4M for Q1 2026, improved from a $4.8M loss in Q1 2025, driven by lower operating expenses. However, revenue declined 38% to $67.9K from $109.3K, and cash decreased sharply to $174.6K from $1.5M at year-end 2025, raising liquidity concerns.

• · Intangible assets (patents and license) net decreased to $13.9M from $14.2M due to amortization of $276,815.
• · Accumulated deficit increased to $44.1M from $40.6M.
• · No financing cash inflows in Q1 2026 vs $2.3M in Q1 2025.
• · Stock-based compensation was $1.6M in Q1 2026 vs $1.0M in Q1 2025.
• · Advertising and marketing expenses decreased to $94K from $282K YoY.
• · Investor relations expenses decreased to $12K from $1.4M YoY.
• · Weighted average shares outstanding increased to 16.5M from 4.6M YoY.
• · Non-controlling interest was immaterial at ($1,533).

19-05-2026

Nextpower Inc. reported strong revenue growth of 20% YoY to $3.56B for fiscal year ended March 31, 2026, driven by a 34% surge in U.S. revenue to $2.73B. Net income increased 13% to $585.9M, and adjusted EBITDA rose 10% to $853.7M. However, gross margin contracted from 34.1% to 32.6% (GAAP) and adjusted gross margin fell from 34.6% to 33.3%, while operating margin declined from 21.6% to 19.6% (GAAP) and adjusted EBITDA margin slipped from 26.2% to 24.0%. Rest of the World revenue declined 11% to $828.7M, and operating cash flow decreased 14% to $562.9M.

• · Rest of the World revenue declined 10.7% YoY to $828.7M, while U.S. revenue grew 34.4% to $2.73B.
• · GAAP gross margin fell from 34.1% to 32.6% and adjusted gross margin fell from 34.6% to 33.3%.
• · GAAP operating margin declined from 21.6% to 19.6% and adjusted EBITDA margin declined from 26.2% to 24.0%.
• · Operating cash flow decreased 14.2% to $562.9M, despite higher net income.
• · R&D expense surged 52.3% to $120.9M, and SG&A expense increased 17.8% to $341.9M.
• · Cost of sales grew 23.0% to $2.40B, outpacing revenue growth of 20.3%.
• · Interest expense dropped 80.0% to $2.6M, and other income net improved to a loss of $19.2M from a loss of $22.0M.
• · Cash and cash equivalents increased 42.9% to $1.09B, and total assets grew 27.6% to $4.07B.
• · Total stockholders' equity rose 43.4% to $2.33B, driven by reduction in accumulated deficit from $2.56B to $1.97B.
• · Net income attributable to Nextpower Inc. was $585.9M (FY2025: $509.2M), with no non-controlling interest in FY2026.
• · Basic EPS increased to $3.96 from $3.55, and diluted EPS increased to $3.84 from $3.47.
• · Weighted-average basic shares outstanding increased 3.1% to 147.98 million.
• · Goodwill increased 31.8% to $489.0M, and other intangible assets net rose 46.6% to $78.0M, likely due to acquisitions.
• · Section 45X credit receivable rose 63.5% to $352.6M.
• · Deferred revenue (current) increased 24.4% to $307.5M, and long-term deferred revenue rose 6.1% to $102.5M.
• · Tax receivable agreement liability decreased 5.6% to $372.7M.

19-05-2026

Eagle Materials Inc. reported revenue of $2,308.7M for the fiscal year ended March 31, 2026, a 2% increase from $2,260.5M in the prior year. However, net earnings declined 9% to $423.8M from $463.4M, and diluted EPS fell 4% to $13.16 from $13.77, driven by a 4% rise in cost of goods sold and a 21% increase in corporate general and administrative expenses. Operating cash flow improved 12% to $614.2M, and the company significantly increased capital expenditures to $416.7M, while also issuing $741.8M in 5.000% senior notes and repurchasing $381.8M of common stock.

• · Cash and cash equivalents surged to $297.9M from $20.4M, a 1,360% increase.
• · Long-term debt increased to $1,745.1M from $1,223.3M, up 43%.
• · Total assets grew to $3,842.2M from $3,264.6M, up 18%.
• · The company issued $741.8M in 5.000% senior notes during FY2026.
• · Share repurchases totaled $381.8M in FY2026, up from $298.3M in FY2025.
• · Dividends paid to stockholders were $32.4M in FY2026, slightly down from $33.7M in FY2025.
• · Cash dividend per share remained flat at $1.00 for FY2026, FY2025, and FY2024.
• · Basic earnings per share declined to $13.24 from $13.88, a 5% decrease.
• · Inventories decreased slightly to $408.4M from $415.2M.
• · Goodwill and intangible assets net decreased to $585.4M from $595.8M.
• · The company made a $15.0M minority investment in FY2026, with no such investment in FY2025.
• · Net cash used in investing activities was $431.7M, up from $370.1M.
• · Net cash provided by financing activities was $95.1M, compared to $(192.9)M used in FY2025.
• · Accumulated other comprehensive losses worsened to $(4.4)M from $(3.1)M.
• · Auditor: Ernst & Young LLP, Dallas, Texas (Firm ID: 42).

19-05-2026

Capital Southwest Corp (CSWC) filed its 10-K annual report for the fiscal year ended March 31, 2026. Net investment income rose 14.6% YoY to $135.5M, driven by a 13.5% increase in total investment income to $232.1M. However, net unrealized depreciation on investments swung to -$25.8M from +$2.4M in the prior year, and the weighted average annual effective yield on debt investments declined to 10.8% from 11.7%.

• · Portfolio companies grew from 121 to 131 YoY, a 8.3% increase.
• · Percentage of debt investments bearing a floating rate decreased slightly to 95.5% from 97.3%.
• · Percentage of investments secured by first lien increased to 90.1% from 88.9%.
• · Weighted average leverage through CSWC security increased to 3.6x from 3.5x.
• · Weighted average EBITDA of portfolio companies declined 15.2% to $15.7M from $18.5M.
• · Annual expenses as a percentage of net assets: operating expenses 2.86%, interest payments 7.37%, income tax 0.11%, total 10.34%.
• · Net asset value (NAV) per share declined from $16.70 to $16.69 over the year ended March 31, 2026 (Fourth Quarter comparison).

19-05-2026

Envirotech Vehicles reported a net loss of $3.99M for Q1 2026 compared to a net loss of $14.04M in Q1 2025, primarily due to a $10.1M goodwill impairment charge in the prior year that did not recur. Revenue surged 281% YoY to $2.25M from $0.59M, but gross profit was negative $(0.19M) versus $0.12M in the prior year period. Operating expenses fell sharply, leading to a reduced operating loss of $(3.77M) from $(13.73M). However, cash used in operations remained high at $3.34M, and the company ended the quarter with a stockholders' deficit of $(8.18M) and total current liabilities far exceeding current assets.

• · Property and equipment, net increased dramatically from $0.48M to $2.25M quarter-over-quarter, driven by $1.84M in construction in progress.
• · Right-of-use asset increased from $0.49M to $1.95M quarter-over-quarter, and operating lease liabilities (short- and long-term) increased from $0.54M to $1.62M.
• · Cash used in operating activities improved to $(3.34M) from $(4.22M) in Q1 2025.
• · No goodwill impairment charge was recorded in Q1 2026 compared to a $10.1M charge in Q1 2025.
• · The company issued 4.57M shares of common stock for cash proceeds of $2.68M, and received $3.82M from debenture issuance during Q1 2026.
• · Total current liabilities of $18.31M exceed total current assets of $6.77M by a significant margin as of March 31, 2026.
• · The company had a stockholders' deficit of $(8.18M) as of March 31, 2026, though this improved slightly from $(8.93M) at year-end 2025.
• · Receivable from related party increased to $1.60M from $1.20M, and prepaid expenses rose to $0.35M from $0.24M.
• · G&A expenses remained virtually flat at $3.57M vs $3.60M year-over-year.
• · Basic and diluted net loss per share improved sharply to $(0.31) from $(6.44) due to the reduced loss and a much higher weighted average share count (12.89M vs 2.18M).

19-05-2026

SunPower Inc. reported net income of $5.3M for Q1 2026, up from $4.8M in Q1 2025, driven by a sharp improvement in gross profit ($44.7M vs $27.4M) and a $30.8M gain in other non-operating income. However, revenue declined 7.2% to $72.8M, operating loss widened to $19.2M from $3.7M, and cash used in operations increased to $25.7M, reflecting deteriorating core operating performance.

• · Total stockholders' deficit improved to $61.5M from $90.1M at year-end 2025, primarily due to net income and equity issuances.
• · Goodwill increased to $75.6M from $62.6M, reflecting acquisition activity.
• · Short-term debt with third parties increased to $13.7M from zero, while short-term debt with related parties remained at $21.5M.
• · Contract liabilities (current) decreased sharply to $12.6M from $20.3M, indicating revenue recognition or fulfillment of obligations.
• · The company issued 4.56 million shares of common stock for $7.0M in cash proceeds during Q1 2026.
• · Interest expense rose to $6.9M from $6.0M, with related party interest and amortization of debt issuance costs of $2.3M.
• · Cash paid for interest increased to $5.3M from $1.4M in the prior year quarter.
• · The company recognized $3.3M in common stock as partial consideration for an acquisition and $6.3M in deferred consideration for the acquisition of Cobalt.
• · Basic EPS declined to $0.04 from $0.06 due to a 55% increase in weighted-average basic shares.
• · Sales commissions surged to $28.6M from $7.7M, a 272% increase, while sales and marketing expenses fell to $5.0M from $8.5M.

19-05-2026

Akari Therapeutics reported a net loss of $14.5M for Q1 2026, widening from $3.7M in Q1 2025, driven by $12.1M in impairment charges on intangible assets and goodwill. Cash decreased to $2.8M from $5.3M at year-end 2025, while total assets fell to $33.9M from $47.9M. The company raised $0.2M in equity financing during the quarter.

• · Goodwill was fully impaired, reducing net book value to $0 from $8.4M.
• · Other intangible assets (AKTX-101) were impaired by $3.7M, net book value $30.3M.
• · Total liabilities remained relatively flat at $19.5M vs $19.6M.
• · Operating expenses surged to $15.8M from $3.5M, primarily due to impairment charges.
• · Net cash used in operating activities was $2.5M vs $2.2M in prior year.
• · Weighted-average shares outstanding increased to 118.8B from 54.6B due to share issuances.

19-05-2026

Lakeside Holding Ltd (LSH) reported a net loss of $2.8M for the nine months ended March 31, 2026, compared to a net loss of $4.4M in the prior-year period, an improvement driven by a $2.6M gain on the sale of its ABL Chicago discontinued operation. Revenue surged to $5.1M from $0.7M, but operating losses widened to $3.4M from $1.5M due to a sharp increase in operating expenses, including $0.5M in credit loss provisions. The company's cash position fell to $1.3M from $4.8M at June 30, 2025, while total equity rose to $13.6M from $2.8M, reflecting significant equity issuances.

• · Total assets increased to $17.8M as of March 31, 2026 from $14.4M at June 30, 2025.
• · Total liabilities decreased to $4.2M from $11.6M, primarily due to the removal of discontinued operation liabilities.
• · Inventories decreased to $22,024 from $96,534.
• · Loan receivable from a third party increased to $8.3M from $11,380, with a $350,000 credit loss allowance.
• · Convertible debts - current decreased to $85,085 from $910,675.
• · Accumulated deficits increased to $8.1M from $5.3M.
• · Basic and diluted net loss per share from continuing operations was $(0.15) for the nine months ended March 31, 2026, compared to $(0.20) in the prior period.
• · The company issued 17,807,229 common shares in a private placement during the nine months ended March 31, 2026, with $1.4M still receivable.
• · 5,300,000 common shares were issued for consulting services, valued at $4.4M.

19-05-2026

DeFi Development Corp. reported Q1 2026 revenue of $2.7M, up 828% YoY from $0.3M, driven by digital asset revenue. However, the company posted a net loss of $83.4M compared to a $0.8M loss in the prior year, primarily due to a $51.0M net loss on digital assets and $22.8M loss from derivative instruments. Operating expenses surged to $57.9M from $1.2M, and cash used in operations increased to $9.8M from $0.8M.

• · Net loss per share (basic and diluted) was $(3.18) for Q1 2026 vs $(0.08) for Q1 2025.
• · Digital assets at fair value totaled $11.3M, with $10.4M pledged as collateral.
• · Non-cash digital asset financing arrangement borrowings were $91.1M, with repayments of $56.7M.
• · The company repurchased $10.5M of common stock during Q1 2026.
• · Cash paid for interest increased to $3.3M from $1,000 in the prior year period.
• · Accumulated deficit grew to $(175.3M) at March 31, 2026 from $(91.8M) at December 31, 2025.

19-05-2026

Northann Corp. reported a net loss of $2.9M for Q1 2026, widening from a $2.6M loss in Q1 2025, as revenue grew 44% to $5.0M but gross profit turned negative due to cost of revenue outpacing sales. The company issued 27.5M shares for capitalized software and 3.3M shares for services, boosting stockholders' equity to $18.4M from $9.0M, while cash fell sharply to $0.24M from $1.03M.

• · Cost of revenue increased 79% YoY to $5.5M, exceeding revenue growth and causing negative gross margin.
• · Selling expenses decreased 62% YoY to $0.39M, while G&A rose 17% to $1.73M.
• · Depreciation and amortization surged to $1.08M from $0.25M, reflecting the capitalized software intangible asset.
• · Operating cash flow worsened to -$1.40M from -$1.01M.
• · The company had no income tax expense in either period.
• · Foreign currency translation provided a $49,665 gain in Q1 2026 vs. a $206,395 loss in Q1 2025.
• · Basic and diluted EPS was -$0.064 in Q1 2026 vs. -$0.028 in Q1 2025, despite a lower share count.

19-05-2026

Kindcard, Inc. (KCRD) filed its 10-K annual report for the fiscal year ended January 31, 2026, reporting a net loss of $210,436, an improvement from the $252,221 net loss in the prior year. Total revenue declined 11.0% to $365,708 from $410,869, while total operating expenses increased to $1,169,622 from $1,132,511. The company's accumulated deficit widened to $1,632,570 from $1,422,134, and total assets fell sharply to $51,413 from $86,018.

• · Cash balance sheet shows a stockholders' deficit of $1,118,209 as of January 31, 2026, worsening from $1,046,493 a year earlier.
• · Cash increased slightly to $9,160 from $9,089, but accounts receivable (net) decreased to $32,526 from $34,728.
• · Intangible assets, net, fell sharply to $9,727 from $39,964.
• · Notes payable rose to $384,817 from $343,246.
• · The company issued 5,160,799 shares for services valued at $129,020 and 250,000 shares in settlement valued at $9,700 during fiscal 2026.
• · Advertising and marketing expense decreased to $2,547 from $4,169, and communications expense fell to $47,273 from $63,328.
• · Depreciation and amortization expense dropped to $26,092 from $80,191.
• · The company had no provision for income taxes in either year.

19-05-2026

RMX Industries reported a net loss of $6.03M for Q1 2026, widening from a $4.53M loss in Q1 2025, driven by a $5.0M total other expense including $2.9M loss on warrant conversion and $2.0M debt discount amortization. Revenue fell to zero from $26,200 in the prior year period, while operating expenses were reduced 62% to $1.03M. The company's accumulated deficit grew to $46.87M and stockholders' equity declined to $23.01M from $26.35M at year-end 2025.

• · Operating expenses decreased 62% YoY to $1.03M, driven by reductions in payroll/compensation (from $979,561 to $421,857) and professional services (from $1,220,593 to $444,546).
• · ).
• · Total other expense increased to $5.0M from $1.87M, primarily due to a $2.9M loss on warrant conversion and $2.0M debt discount amortization.
• · Cash used in operating activities improved to $570,519 from $1.37M in the prior year period.
• · The company issued 553,112 shares of Class A common stock through conversion of notes payable via warrant exercise, valued at $1.94M.
• · Notes payable and interest payable increased to $154,141 from $67,904, reflecting higher debt levels.
• · Property and equipment, net declined to $20,510 from $25,998 due to depreciation.
• · Goodwill and intangibles remained nearly flat at $30.04M.

19-05-2026

For Q1 2026, BioForce Nanosciences Holdings reported no revenue and a net loss of $102,411, an 89% improvement from the $935,457 net loss in Q1 2025, which included an $802,000 loss on liability settlement. The company's cash position improved to $6,347 from $786 at year-end 2025, though total liabilities rose to $727,301 from $619,329 and the accumulated deficit widened to ($162,514,528).

• · The company has no revenue and relies on cash from financing activities and related parties.
• · General and administrative expenses decreased 56.8% from $27,707 in Q1 2025 to $11,983 in Q1 2026, contributing to the narrower loss.
• · Board of Directors Compensation remained flat at $105,750 per quarter.
• · The company issued 4,250,000 shares of common stock in Q1 2025 to satisfy $2,975,000 in liabilities, increasing the share count from 29,271,755 to 33,521,755; no additional shares were issued in Q1 2026.
• · The company is a shell company (Entity Shell Company: false), but per the filing it is not classified as a shell at the time of this filing.
• · Cash from operations provided $7,088 in Q1 2026 vs. using $15,215 in Q1 2025, a favorable swing due to reduced operating loss and changes in accrued expenses.

19-05-2026

Wellgistics Health, Inc. reported a net loss of $7.74M for Q1 2026, a significant improvement from the $32.43M loss in Q1 2025. However, net revenues collapsed 85.6% YoY to $1.56M from $10.86M, driven by a 97.9% drop in distribution service revenue ($0.23M vs $10.67M). While total stockholders' deficit deepened to $15.06M from $12.45M, cash increased to $51,730 and the company raised $6.0M in convertible notes.

• · Q1 2026 operating expenses fell 80.7% YoY to $6.19M from $32.04M, driven primarily by a $27.77M drop in stock-based compensation.
• · Stock-based compensation in Q1 2026 was $1.36M versus $27.77M in Q1 2025.
• · Allowance for credit losses stood at $941,052 or 48.7% of gross billed receivables ($1.93M) at March 31, 2026.
• · Inventory net of reserves was $1.71M against a gross cost of $8.15M, with a $6.44M reserve for obsolescence, mainly related to FDNS ($5.99M).
• · Total debt obligations include $6.57M in convertible notes (current), $8.60M current portion of debt, and $12.60M in long-term notes payable.
• · Interest expense increased to $2.07M from $1.09M YoY due to higher debt levels.
• · The company issued 10 million shares to settle accrued compensation ($2.59M) and 6.5 million shares to settle vendor/debt obligations ($1.36M) in Q1 2026.
• · Net cash used in operations was $3.41M in Q1 2026, compared to $1.35M in Q1 2025.
• · Liquidity position remains tight with cash of only $51,730 and a working capital deficit of $29.44M.
• · Weighted average diluted shares increased to 104.6M from 51.9M YoY.

19-05-2026

19-05-2026

Under Armour reports a net loss of $495.6M for fiscal year 2026, significantly widening from a $201.3M loss in the prior year, driven by a 3.8% decline in net revenues to $5.0B and a $297.6M income tax expense versus a $2.9M tax benefit last year. While gross margin contracted 240 bps to 45.5%, the company reduced SG&A expenses by 11.8% and incurred $127.7M in restructuring charges as part of a transformation plan. Geographically, the business is mixed: North America declined 7.9% and Asia-Pacific fell 4.8%, but EMEA grew 8.6% and Latin America increased 8.7%.

• · Footwear net revenues declined 10.8% to $1.08B, the worst-performing product category.
• · Income tax expense swung from a $2.9M benefit to a $294.8M charge, contributing heavily to the wider net loss.
• · Wholesale channel revenues fell 4.9% to $2.83B, while DTC declined 1.7% to $2.05B.
• · Restructuring charges more than doubled to $127.7M, with remaining costs of $44.3M to be incurred (total program $305M).

19-05-2026

Sypris Solutions reported a net loss of $4.1M for Q1 2026 Q1, a sharp deterioration from a $0.9M loss in the prior-year-ago quarter, as revenue fell 12.5% to $25.8M and gross profit collapsed 75.6% to $0.8M. Operating loss widened to $3.6M from $0.1M, while cash used in operations improved to $2.3M from $5.5M. The company also took on new debt, with a $1.2M loan payable and a $2.0M related-party note due within a year.

• · SG&A expense increased 26.5% YoY to $4.4M, contributing to the wider operating loss.
• · Interest expense rose 75.5% YoY to $0.5M.
• · Inventory increased slightly to $52.5M from $52.5M at year-end 2025.
• · Accounts receivable decreased to $9.5M from $9.8M.
• · Total liabilities increased to $91.4M from $90.0M at year-end 2025.
• · Stockholders' equity fell to $13.8M from $17.8M.
• · The company recorded a $0.3M provision for excess and obsolete inventory in Q1 2026, up from $0.1M in Q1 2025.
• · Capital expenditures were $0.2M in Q1 2026 vs. virtually nil in the prior year.
• · The company had $0.5M drawn on its working capital line of credit at quarter end.
• · No dividends were declared.

19-05-2026

ShorePower Technologies reported a net loss of $139,655 for Q1 2026, a sharp reversal from net income of $5,891 in Q1 2025, as total revenue collapsed 98.6% to $2,260 from $164,657. The company recorded no service revenue or product sales in the current quarter, with gross margin swinging from a positive $125,352 to a negative $11,977. Operating expenses rose 4.8% to $107,572, driven by higher professional fees and G&A, while the company's accumulated deficit widened to $3,417,796 and total stockholders' deficit reached $2,062,041.

• · The company had no service revenue or product sales in Q1 2026, compared to $40,923 and $120,591 respectively in Q1 2025.
• · Gross margin turned negative at ($11,977) in Q1 2026 versus a positive $125,352 in Q1 2025.
• · Operating expenses increased 4.8% to $107,572, with professional fees up 142.1% to $9,788 and G&A up 45.1% to $37,292, partially offset by a 54.1% decline in consulting to $10,492.
• · Interest expense rose 19.4% to $20,106.
• · Total liabilities increased 4.1% to $2,137,041, driven by higher accounts payable and accrued expenses.
• · Stockholders' deficit worsened to ($2,062,041) from ($1,998,886) at year-end 2025.
• · Cash increased 24.6% to $19,156, primarily from $60,000 in financing proceeds (common stock sales), while operating activities used $56,218.
• · The company issued $15,000 of common stock for an intangible asset in Q1 2026.
• · Customer concentration: In Q1 2025, Customer A represented 57.4% of revenue and Customer B 40.6%; no customer concentration data was provided for Q1 2026.
• · Basic and diluted loss per share was ($0.00) in Q1 2026 versus earnings of $0.010 in Q1 2025.

19-05-2026

Novelis Inc. reported fiscal 2026 net sales of $18,434M, up 7.5% from $17,149M in fiscal 2025, driven by higher local market premiums (LMP up 144% YoY to $895/metric tonne). However, total shipments declined 6.1% to 3,731 kt from 3,972 kt, with North America rolled product shipments falling 12% YoY. Adjusted EBITDA decreased 8.7% to $1,645M from $1,802M, primarily due to volume declines in North America.

• · North America Adjusted EBITDA dropped from $640M in fiscal 2025 to $435M in fiscal 2026, a decline of $205M, primarily due to a $222M negative volume impact.
• · Europe Adjusted EBITDA improved from $306M to $379M, driven by $112M positive volume impact.
• · Asia Adjusted EBITDA decreased from $347M to $311M, with a $73M negative impact from conversion premium and product mix.
• · South America Adjusted EBITDA increased from $504M to $521M, with $17M positive volume impact.
• · Total rolled product shipments in Q4 fiscal 2026 (three months ended March 31, 2026) were 844 kt, down 12% from 957 kt in Q4 fiscal 2025.
• · North America rolled product shipments in Q4 fiscal 2026 were 302 kt, down 19% from 375 kt in Q4 fiscal 2025.
• · Availability under committed credit facilities decreased to $1,502M as of March 31, 2026 from $1,739M a year earlier.
• · The weighted average local market premium surged 144% to $895 per metric tonne in fiscal 2026 from $367 in fiscal 2025.

19-05-2026

Bravo Multinational Inc. (BRVO) reported a net loss of $129,175 for Q1 2026, up 81.9% from a $71,019 loss in Q1 2025, driven by a 122% increase in board of director fees to $146,650 and a $28,588 legal settlement expense. Cash and cash equivalents surged to $26,051 from $111 at year-end 2025, while total liabilities rose to $1,210,813 from $1,055,698, and the accumulated deficit widened to $(96,563,824). The company remains in a stockholders' deficit of $(1,184,762).

• · Professional fees decreased 64.9% to $8,892 in Q1 2026 from $25,350 in Q1 2025.
• · General and administrative expenses rose 15.7% to $2,221 from $1,919.
• · Net cash provided by operating activities was $24,190 in Q1 2026 vs. $(25,093) used in Q1 2025.
• · Due to related parties increased to $371,053 from $369,303.
• · Accrued board of directors fees rose to $702,050 from $555,400.
• · No revenue was reported for either period.

19-05-2026

Summit Networks Inc. (SNTW) reported a net loss of $64,760 for the three months ended March 31, 2026, an improvement from a net loss of $82,982 in the same period of 2025. Operating expenses decreased to $58,937 from $82,982, driven by lower general and administrative costs. However, the company incurred $5,823 in interest expense in the current period versus none in the prior year, and cash used in operating activities remained high at $60,041.

• · The company had no revenue in either period; all expenses are operating and interest costs.
• · Accumulated deficit increased from $1,840,134 at Dec 31, 2025 to $1,904,894 at Mar 31, 2026.
• · Total stockholders' deficit worsened from $(892,467) at Dec 31, 2025 to $(957,227) at Mar 31, 2026.
• · Depreciation expense was $573 in Q1 2026 vs $0 in Q1 2025.
• · Amortization of shares pre-issued for services was $3,235 in Q1 2026 vs $0 in Q1 2025.
• · Prepaid share-based payments to consultants decreased from $6,147 at Dec 31, 2025 to $2,912 at Mar 31, 2026.
• · Interest paid in cash was $5,416 in Q1 2026 vs $0 in Q1 2025.
• · No equipment purchases were made in Q1 2026 vs $6,879 in Q1 2025.
• · The company's cash position increased to $121,898 at Mar 31, 2026 from $94,559 at Dec 31, 2025, primarily due to related party loans.

19-05-2026

Doximity's fiscal 2026 revenue grew 13% YoY to $644.9M, with the number of high-value customers (≥$500K revenue) rising to 125 from 118. However, net income declined 12% YoY to $196.1M (from $223.2M), and operating margins compressed as R&D spending surged 40% and stock-based compensation rose 68%, outpacing revenue growth. Gross margin also ticked down slightly to 89% from 90%.

• · Stock-based compensation surged 68% to $121.6M in FY2026, up from $72.4M in FY2025.
• · R&D expense grew 40% YoY to $130.7M, representing 20% of revenue vs 16% a year ago.
• · Total operating expenses increased 25% YoY to $359.6M, outpacing revenue growth of 13%.
• · Provision for income taxes rose 34% to $54.0M, contributing to the net income decline.
• · The number of customers with at least $500K in annual revenue grew by 6% to 125, compared to 118 in FY2025.
• · Sales and marketing expense increased 12% YoY to $163.6M, but as a percentage of revenue it improved to 25% from 26%.

19-05-2026

Byrn, Inc. reported a net loss of $30,937 for Q1 2026, nearly double the $16,410 loss in Q1 2025, driven by a 89% increase in administrative expenses to $30,937. The company reduced its total liabilities from $96,612 to $36,440 by issuing 30,015,577 common shares to settle related party debt, but remains in a stockholders' deficit of $34,263 and holds zero cash.

• · The company had zero cash at both March 31, 2026 and December 31, 2025.
• · Basic and diluted loss per common share was $0.00 for both Q1 2026 and Q1 2025.
• · Weighted average shares outstanding increased from 419,763,612 in Q1 2025 to 450,000,000 in Q1 2026.
• · Accounts payable rose from $7,577 to $16,221, while related party payables fell from $89,035 to $20,219.
• · Prepaid expenses and accounts receivable other were zero at December 31, 2025 but totaled $2,178 at March 31, 2026.
• · Net cash used in operating activities was $24,470 in Q1 2026 vs $15,297 in Q1 2025.
• · The company had no investing activities in either period.

19-05-2026

Oxley Bridge Acquisition Ltd reported net income of $2.1M for Q1 2026, a significant turnaround from a net loss of $12,962 in Q1 2025, driven by $2.27M in income on trust investments. However, operating expenses surged to $162,277 from $12,962, and cash used in operations was $162,173, while cash and cash equivalents declined 16.6% to $816,134 from $978,307 at year-end 2025.

• · Basic and diluted net income per share for both Class A and Class B shares was $0.07 in Q1 2026.
• · Total assets increased to $261,479,004 as of March 31, 2026 from $259,327,478 at December 31, 2025.
• · Shareholders' deficit widened to $(11,210,518) from $(11,056,054) due to remeasurement of Class A shares to redemption value.
• · Net cash used in operating activities was $162,173 in Q1 2026, compared to $0 in Q1 2025.
• · The company had 25,300,000 Class A shares subject to possible redemption at a redemption value of approximately $10.30 per share as of March 31, 2026.

19-05-2026

Movano Inc. (MOVE) reported total revenue of $510,000 for Q1 2026, up 147.6% from $206,000 in Q1 2025, driven by the launch of an AI Platform and services segment ($475,000) following a merger. However, the company's net loss remained substantial at $5,005,000, only slightly improved from $5,178,000 a year ago, and the legacy Connected devices and services segment saw revenue decline 83.0% to $35,000. The balance sheet was transformed by the merger, with total assets surging to $604,483,000 from $5,600,000 at year-end 2025, primarily due to $518,263,000 in goodwill and $574,469,000 in preferred stock issuance.

• · Net loss per share improved to $(3.13) in Q1 2026 from $(5.35) in Q1 2025.
• · Stock-based compensation increased to $2,178,000 in Q1 2026 from $299,000 in Q1 2025.
• · Depreciation and amortization rose to $326,000 in Q1 2026 from $38,000 in Q1 2025.
• · General and administrative expenses increased to $3,393,000 in Q1 2026 from $1,637,000 in Q1 2025.
• · Technology and infrastructure expenses decreased to $822,000 in Q1 2026 from $2,364,000 in Q1 2025.
• · Sales and marketing expenses decreased to $304,000 in Q1 2026 from $763,000 in Q1 2025.
• · Cash used in operating activities was $4,288,000 in Q1 2026, nearly flat compared to $4,303,000 in Q1 2025.
• · Cash provided by investing activities was $30,441,000 in Q1 2026, driven by $36,679,000 cash acquired in business combination, partially offset by $6,238,000 in property and equipment purchases.
• · Cash provided by financing activities was $350,000 in Q1 2026, down from $758,000 in Q1 2025.
• · Total liabilities increased to $28,480,000 at March 31, 2026 from $9,074,000 at December 31, 2025.
• · Stockholders' equity swung from a deficit of $(3,474,000) at December 31, 2025 to $576,003,000 at March 31, 2026.
• · The merger involved issuance of Series B, C, and D preferred stock with amounts of $2,576,000, $250,737,000, and $323,732,000 respectively.
• · Deferred revenue (current and non-current) totaled $4,379,000 at March 31, 2026, compared to $12,000 at December 31, 2025.
• · Finance lease liabilities (current and non-current) totaled $10,415,000 at March 31, 2026, with no such liabilities at December 31, 2025.